Back to search
Rivastigmine Toxicity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rivastigmine Toxicity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rivastigmine Toxicity trials you may qualify forThis study aims to evaluate the clinical efficacy of rivastigmine in reversing the full spectrum of toxic anticholinergic delirium, with a specific focus on hyp…
Antimuscarinic delirium (AMD) is a common and dangerous toxicology condition caused by poisoning by medications and other chemicals that block muscarinic recept…
Rivastigmine is a carbamate, approved by the FDA for the treatment of mild to moderate dementia associated with Alzheimer's and Parkinson's diseases. Studies co…